The bone graft substitutes market focuses on materials used to repair or regenerate bone lost due to injury, disease, or surgery. These substitutes include synthetic materials, demineralized bone matrices, and biologically derived grafts, commonly used in spinal fusion, dental implants, and trauma surgeries. With a rise in orthopedic procedures, aging populations, and advancements in biomaterials, demand for effective and safe bone graft alternatives continues to grow. Innovations in 3D printing, bioactive ceramics, and minimally invasive techniques are also expanding clinical applications, helping improve healing outcomes and reduce recovery time.
According to Fortune Business Insights, the global bone graft substitutes market was valued at USD 3.81 billion in 2023 and is projected to grow from USD 4.04 billion in 2024 to USD 6.67 billion by 2032, exhibiting a CAGR of 6.5% during the forecast period (2024–2032). In 2023, North America dominated the bone graft substitutes market with a market share of 46.19%.
In October 2023, Orthofix Medical Inc. launched OsteoCove, a bioactive synthetic graft available in both putty and strip formats. This innovation indicates the rise of advanced synthetic grafts tailored for easier application and high compliance.